• Arcus Biosciences to Provide a Mid-Year Update on Clinical and Preclinical Programs

    HAYWARD, Calif.–(BUSINESS WIRE)–Jun 11, 2019–. Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage biopharmaceutical company focused¬†…

    Read More
  • 0 0